Literature DB >> 34104921

A case with Gaucher disease unable to reach enzyme replacement therapy because of COVID-19 quarantine: The first case from Turkey.

Merve Koç Yekedüz1, Engin Köse1, Fatma Tuba Eminoğlu1.   

Abstract

Entities:  

Year:  2021        PMID： 34104921      PMCID： PMC8152655          DOI： 10.5152/TurkArchPediatr.2021.21023

Source DB:  PubMed          Journal:  Turk Arch Pediatr        ISSN： 2757-6256


× No keyword cloud information.
  9 in total

1.  Home treatment with intravenous enzyme replacement therapy for Gaucher disease: an international collaborative study of 33 patients.

Authors:  A Zimran; C E Hollak; A Abrahamov; M H van Oers; M Kelly; E Beutler
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

Review 2.  Inborn errors of metabolism underlying primary immunodeficiencies.

Authors:  Nima Parvaneh; Pierre Quartier; Parastoo Rostami; Jean-Laurent Casanova; Pascale de Lonlay
Journal:  J Clin Immunol       Date:  2014-08-01       Impact factor: 8.317

3.  Gaucher disease and SARS-CoV-2 infection: Emerging management challenges.

Authors:  Pramod Mistry; Manisha Balwani; Deborah Barbouth; T Andrew Burrow; Edward I Ginns; Ozlem Goker-Alpan; Gregory A Grabowski; Reena V Kartha; Priya S Kishnani; Heather Lau; Chung U Lee; Grisel Lopez; Gustavo Maegawa; Seymour Packman; Carlos Prada; Barry Rosenbloom; Tamanna Roshan Lal; Rapheal Schiffmann; Neal Weinreb; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2020-05-11       Impact factor: 4.797

4.  Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?

Authors:  Marcio Andrade-Campos; Beatriz Escuder-Azuara; Laura López de Frutos; Irene Serrano-Gonzalo; Pilar Giraldo
Journal:  Blood Cells Mol Dis       Date:  2020-07-14       Impact factor: 3.039

5.  The dark side of COVID-19: The need of integrated medicine for children with special care needs.

Authors:  Chiara Leoni; Valentina Giorgio; Roberta Onesimo; Luigi Tarani; Mauro Celli; Angelo Selicorni; Giuseppe Zampino
Journal:  Am J Med Genet A       Date:  2020-06-24       Impact factor: 2.802

6.  Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York.

Authors:  Luca Fierro; Nora Nesheiwat; Hetanshi Naik; Praveena Narayanan; Pramod K Mistry; Manisha Balwani
Journal:  Mol Genet Metab       Date:  2020-12-15       Impact factor: 4.797

7.  Impact of Gaucher disease on COVID-19.

Authors:  Ari Zimran; Jeff Szer; Shoshana Revel-Vilk
Journal:  Intern Med J       Date:  2020-07       Impact factor: 2.048

8.  The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective.

Authors:  Mohamed A Elmonem; Amaya Belanger-Quintana; Andrea Bordugo; Ritma Boruah; Elisenda Cortès-Saladelafont; Mounika Endrakanti; Pilar Giraldo; Sarah Catharina Grünert; Neerja Gupta; Madhulika Kabra; Ina Knerr; Johannes Krämer; Alice Kuster; Elena Levtchenko; Lock-Hock Ngu; M Mar Rovira-Remisa; Jörn Oliver Sass; Jolanta Sykut-Cegielska; Albina Tummolo; Lambertus P van den Heuvel
Journal:  Mol Genet Metab       Date:  2020-09-25       Impact factor: 4.797

Review 9.  SARS-CoV-2 infection in a patient with propionic acidemia.

Authors:  Anna Caciotti; Elena Procopio; Francesca Pochiero; Silvia Falliano; Giuseppe Indolfi; Maria Alice Donati; Lorenzo Ferri; Renzo Guerrini; Amelia Morrone
Journal:  Orphanet J Rare Dis       Date:  2020-10-28       Impact factor: 4.123
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.